Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...
In a settlement reached on June 26, Johnson & Johnson agreed to pay up to $263 million to the state of New York and Nassau and Suffolk counties to resolve the plaintiffs’ claims that the pharmaceutical giant had contributed to the nationwide opioid crisis that has...
The first bellwether trial in the sprawling multidistrict opioid litigation began on May 3 in West Virginia federal court. The plaintiffs in the trial, Cabell County and the city of Huntington, West Virginia, which many consider the epicenter of the opioid drug...
In response to motions opposing additional bellwether trials filed on March 26 and March 29 by the nations’ biggest pharmacy chains, Judge Aaron Dan Polster issued an order rejecting the objections and reaffirming his plan to schedule an additional five trials in the...
In a statement to the bankruptcy court on March 23, the family of Raymond Sackler advised that unless the injunction shielding the Sackler family from litigation was extended, they would withdraw their proposed $4.275 billion cash contribution to the settlement fund...
As part of a global resolution to the opioid litigation, pharmaceutical manufacturers and distributors have agreed to make public millions of pages of internal documents that detail the aggressive marketing and sales methods that fueled the epidemic. OxyContin...
The DOJ has announced that Purdue Pharma, the maker of OxyContin, the opioid painkiller which had a big role in the U.S. opioid epidemic, has agreed to plead guilty to three federal criminal charges in addition to paying $8.3 billion. The agreement does not exonerate...
On Tuesday, October 13, J&J announced that it was increasing its settlement deal by $1 billion for a total of $5 billion in its efforts to put an end to almost 3,000 opioid lawsuits. This is part of the original $48 billion settlement framework proposed in 2019...
The Oklahoma court has ruled that it will allow organizations to file friend of the court briefs in support of J&J’s efforts to overturn a $465 million judgement for their role in contributing to the opioid epidemic in Oklahoma. The key issue in last week’s brief...
On July 27, the judge overseeing the National Prescription Opiate Multidistrict Litigation denied the Plaintiffs’ Executive Committee’s motion to establish a $3 billion common benefit fee fund, stating that the time was not right for a “one size fits all” common...
